Contract Service Directory

Lupin Limited





Company Headquarters

Suite 1 Victoria Court
Cheshire, WA160PF
United Kingdom

Contract Service Directory

    Related Content

    • Breaking News | Promotions & Moves
      Boyds Opens US Office in PA

      Boyds Opens US Office in PA

      Welcomes Katy Rudnick as VP and head of US regulatory affairs.
      09.13.21

    • Promotions & Moves
      CROS NT Appoints President of North American Ops

      CROS NT Appoints President of North American Ops

      Paul has more than 25 years of experience serving customers and managing clinical trials
      05.30.17

    • APIs | cGMP Manufacture | Industry News
      Cambrex Expands Capacity and Capabilites in Sweden

      Cambrex Expands Capacity and Capabilites in Sweden

      Installs new multi-purpose reactors, adds continuous flow technology at Karlskoga Facility
      05.30.17


    • cGMP Manufacture | Clinical Trial Materials | Formulation Development | Industry News

      Quotient Clinical Appoints Chief Commercial Officer

      Kalim to support further expansion of global commercial footprint
      05.30.17

    • Breaking News | Promotions & Moves
      Recipharm Makes Appointment in the UK & Ireland

    • Breaking News | Drug Development | Drug Discovery | Facilities | Industry News
      Evotec Opens U.S. HQ in NJ

      Evotec Opens U.S. HQ in NJ

      Also unveils 20,000 square-foot facility expansion
      05.26.17


    • Breaking News | Drug Development | Industry News

      Lupin Acquires Specialty Product Portfolio in Germany

      Temmler’s business has a strong strategic fit with Lupin’s Hormosan business
      07.27.15

    • Breaking News | cGMP Manufacture | Drug Development | Drug Discovery | Facilities | Formulation Development | Industry News | R&D | Supply Chain

      Lupin Acquires Gavis to Expand US Generic Business

      Gavis’s NJ-based manufacturing facility will become Lupin's first manufacturing site in the US
      07.24.15

    • Breaking News | Formulation Development | Industry News | R&D | Supply Chain

      Lupin to Acquire GAVIS for $880M

      Will expand U.S. generics business and gain U.S. manufacturing site
      07.23.15


    • Capsules | GMPs/GCPs | Inspections | Regulatory Affairs | Trials & Filings

      Lupin Launches Generic Cymbalta

      Lilly sees expected generic competition for CNS drug
      Gil Roth 12.12.13

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | GMPs/GCPs | Inspections | Regulatory Affairs | Trials & Filings

      Trials & Filings in Brief: Dec. 12, 2013

      Hisamitsu, ImmunoCellular Therapeutics, Kyowa Hakko Kirin, Lupin, Mallinckrodt, Medivir, Naurex, Orexo, Synta
      Gil Roth 12.12.13

    • Breaking News | Collaborations & Alliances

      Lupin, Salix Expand Rifaximin Pact

      Lupin Ltd. has granted Salix Pharmaceuticals, Ltd. exclusive worldwide rights (except for India) to use Lupin technology for all rifaximin products for human use.
      04.06.11